Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
gene therapy
3
×
life sciences
national blog main
national top stories
3
×
new york blog main
3
×
san francisco blog main
boston blog main
boston top stories
new york top stories
san diego blog main
san francisco top stories
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
amgen
astellas pharma
atlas venture
audentes therapeutics
avalon ventures
aveo oncology
avidity biosciences
biogen
biomarin
biotech
bluebird bio
boston
bristol-myers squibb
cerevel therapeutics
clinical data
drug pricing
drugs
duchenne muscular dystrophy
dyne therapeutics
egfr
facioscapulohumeral muscular dystrophy
glaxosmithkline
hemophilia
ifm therapeutics
What
data
3
×
drug
medical
advanced
ago
arrival
award
bio
biotechs
cancer
close
considering
death
decades
dems
diseases
dyne
early
expected
experimental
eyes
forward
gene
genetic
given
having
heated
hemophilia
humans
immunotherapy
ipo
ipos
long
longer
lung
market
medicines
meeting
muscle
past
Language
unset
Current search:
data
×
" national top stories "
×
" new york blog main "
×
" gene therapy "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race